160 related articles for article (PubMed ID: 2162847)
1. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
Fantini J; Rognoni JB; Theveniau M; Pommier G; Marvaldi J
J Cell Physiol; 1990 Jun; 143(3):468-74. PubMed ID: 2162847
[TBL] [Abstract][Full Text] [Related]
2. Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells.
Fantini J; Rognoni JB; Culouscou JM; Pommier G; Marvaldi J; Tirard A
J Cell Physiol; 1989 Oct; 141(1):126-34. PubMed ID: 2674159
[TBL] [Abstract][Full Text] [Related]
3. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
Fantini J; Rognoni JB; Verrier B; Lehmann M; Roccabianca M; Mauchamp J; Marvaldi J
Eur J Cell Biol; 1990 Feb; 51(1):110-9. PubMed ID: 2328732
[TBL] [Abstract][Full Text] [Related]
4. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
5. Release of carcinoembryonic antigen from human tumor cells by phosphatidylinositol-specific phospholipase C: highly effective extraction and upregulation from LS-174T colonic adenocarcinoma cells.
Gouin E; Ouary M; Pogu S; Saï P
Arch Biochem Biophys; 1993 Oct; 306(1):125-32. PubMed ID: 8215392
[TBL] [Abstract][Full Text] [Related]
6. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6].
Baghdiguian S; Pichon J; Marvaldi J; Fantini J
Bull Cancer; 1991; 78(9):807-17. PubMed ID: 1751832
[TBL] [Abstract][Full Text] [Related]
7. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
Baghdiguian S; Verrier B; Marvaldi J; Fantini J
J Cell Physiol; 1992 Jan; 150(1):168-74. PubMed ID: 1730780
[TBL] [Abstract][Full Text] [Related]
8. [Suramin induces lysosomal storage disorder in HT29-D4 cells during a mechanism of polarized endocytosis].
Baghdiguian S; Boudier JA; Verrier B; Zappitelli JP; Fantini J
C R Acad Sci III; 1992; 314(2):67-73. PubMed ID: 1559184
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
10. The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
Rabenandrasana C; Baghdiguian S; Roccabianca M; Brunet M; Marvaldi J; Fantini J
Cancer Lett; 1990 Sep; 53(2-3):109-15. PubMed ID: 2208069
[TBL] [Abstract][Full Text] [Related]
11. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
12. Small intestinal differentiation in human colon carcinoma HT29 cells has distinct effects on the lateral diffusion of lipids (ganglioside GM1) and proteins (HLA class 1, HLA class 2, and neoplastic epithelial antigens) in the apical cell membrane.
Magnusson KE; Gustafsson M; Holmgren K; Johansson B
J Cell Physiol; 1990 May; 143(2):381-90. PubMed ID: 2332458
[TBL] [Abstract][Full Text] [Related]
13. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium.
Fantini J; Verrier B; Robert C; Pic P; Pichon J; Mauchamp J; Marvaldi J
Exp Cell Res; 1990 Jul; 189(1):109-17. PubMed ID: 2161345
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant phenotype influences the differentiation of a human colon carcinoma cell line.
Rimet O; Mirrione A; Barra Y
Biochem Biophys Res Commun; 1999 May; 259(1):43-9. PubMed ID: 10334913
[TBL] [Abstract][Full Text] [Related]
15. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. Unique apical sorting of insulin-like growth factor binding protein-6 in differentiated human colon cancer cells.
Remacle-Bonnet M; Garrouste F; el Atiq F; Marvaldi J; Pommier G
J Clin Invest; 1995 Jul; 96(1):192-200. PubMed ID: 7542277
[TBL] [Abstract][Full Text] [Related]
16. Convergent effects of growth factors, hormones, and fibronectin are necessary for the enterocyte differentiation of a colon adenocarcinoma cell line (HT29-D4).
Rognoni JB; Pichard V; Honore S; Rigot V; Lehmann M; Roccabianca M; Carles G; Luis J; Marvaldi J; Briand C
Differentiation; 1998 Sep; 63(5):305-17. PubMed ID: 9810709
[TBL] [Abstract][Full Text] [Related]
17. Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines.
Shi ZR; Tsao D; Kim YS
Cancer Res; 1983 Sep; 43(9):4045-9. PubMed ID: 6871845
[TBL] [Abstract][Full Text] [Related]
18. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
Baghdiguian S; Verrier B; Gerard C; Fantini J
Cancer Lett; 1992 Feb; 62(1):23-33. PubMed ID: 1311629
[TBL] [Abstract][Full Text] [Related]
19. Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme.
Naghibalhossaini F; Ebadi P
Cancer Lett; 2006 Mar; 234(2):158-67. PubMed ID: 15893415
[TBL] [Abstract][Full Text] [Related]
20. Establishment of polarized endocytosis in differentiable intestinal HT29-18 subclones.
Godefroy O; Huet C; Ibarra C; Dautry-Varsat A; Louvard D
New Biol; 1990 Oct; 2(10):875-86. PubMed ID: 2078556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
